From: Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy
Characteristic | Total (n = 81) | Baseline eGFR< 60 | ||
---|---|---|---|---|
Yes(n = 25) | No(n = 56) | p | ||
Age, yr | 41.8 ± 12.1 | 49.1 ± 11.8 | 38.6 ± 10.9 | < 0.001 |
Male, n(%) | 34(42.0) | 8(32.0) | 26(46.4) | 0.331 |
Serum Creatinine, μmol/L | 101.1 ± 56.0 | 159.4 ± 64.5 | 75.1 ± 22.5 | < 0.001 |
Albumin, g/L | 40.4 ± 5.0 | 38.5 ± 4.1 | 41.2 ± 5.1 | 0.010 |
24 h Proteinuria, g | 1.3 ± 1.3 | 1.6 ± 1.4 | 1.2 ± 1.2 | 0.132 |
eGFR, mL/min/1.73m2 | 81.7 ± 33.4 | 40.7 ± 12.6 | 100.0 ± 21.2 | < 0.001 |